This paper reviews the role of surface roughness in the osteogenic response to implant materials. Cells in the osteoblast lineage respond to roughness in cell-maturation-specific ways, exhibiting surface-dependent morphologies and growth characteristics. MG63 cells, a human osteoblast-like osteosarcoma cell line, respond to increasing surface roughness with decreased proliferation and increased osteoblastic differentiation. Alkaline phosphatase activity and osteocalcin production are increased. Local factor production is also affected; production of both TGF-β1 and PGE2 is increased. On rougher surfaces, MG63 cells exhibit enhanced responsiveness to 1,25-(OH)2D3. Prostaglandins mediate the effects of surface roughness, since indomethacin prevents the increased expression of differentiation markers in these cells.
Aisa MC, Rahman S., Senin U., Maggio D., Russell RG (1996). Cathepsin B activity in normal human osteoblast-like cells and human osteoblastic osteosarcoma cells (MG-63): regulation by interleukin-1 beta and parathyroid hormone. Biochim Biophys Acta1290:29-36.
2.
Akiyama SK (1996). Integrins in cell adhesion and signaling. Human Cell9:181-186.
3.
Albelda SM, Buck CA ( 1990). Integrins and other cell adhesion molecules. FASEB J4:2868-2880.
4.
Albrektsson T., Branemark P-I., Hansson HA, Lindstrom J. (1981). Osseointegrated titanium implants. Requirements for ensuring a long-lasting, direct bone-to-implant anchorage in man. Acta Orthop Scand52:155-170.
5.
Anderson HC (1984). Matrix vesicle calcification: review and update . In: Bone and mineral research. Pick WA, editor. Amsterdam: Excerpta Medica, pp. 109-149.
6.
Batzer R., Liu Y., Cochran DL, Szmuckler-Moncler S., Dean DD, Boyan BD, et al. (1998). Prostaglandins mediate the effects of titanium surface roughness on MG63 osteoblast-like cells and alter cell responsiveness to 1α,25-(OH)2D3. J Biomed Mater Res41:489-496.
7.
Bellows CG, Aubin JE, Heersche JN (1991). Initiation and progression of mineralization of bone nodules formed in vitro: the role of alkaline phosphatase and organic phosphate. Bone Miner14:27-40.
8.
Bobyn JD, Pilliar RM, Cameron HU, Weatherby GC, Kent GM ( 1980). The effect of porous surface configuration on the tensile strength of fixation of implants by bone ingrowth. Clin Orthop149:291-298.
9.
Bodine RL, Mohammed CI (1970). Gross and microscopic studies of a human mandible with a 12-year old subperiosteal implant denture. Dent Clin North Am14 :145-159.
10.
Bolander ME (1992). Regulation of fracture repair by growth factors . Proc Soc Exp Biol Med200:165-170.
11.
Bonewald LF, Mundy GR (1990). Role of transforming growth factor-beta in bone remodeling. Clin Orthop Rel Res250:261-276.
12.
Bonewald LF, Schwartz Z., Swain LD, Ramirez V., Poser J., Boyan BD (1990). Stimulation of plasma membrane and matrix vesicle enzyme activity by transforming growth factor-β in osteosarcoma cell cultures . J Cell Physiol145:200-206.
13.
Bonewald LF, Wakefield LM, Oreffo RO, Escobedo A., Twardzik DR, Mundy GR (1991). Latent forms of transforming growth factor-β (TGFβ) derived trom bone cultures: identification of a naturally occurring 100 kDa complex with similarity to recombinant latent TGFβ. Molec Endocrinol5:741-751.
14.
Bonewald LF, Kester MB, Schwartz Z., Swain LD, Khare AG, Johnson TL, et al. (1992). Effects of combining transforming growth factor β and 1,25-dihydroxyvitamin D3 on differentiation of a human osteosarcoma (MG-63). J Biol Chem267:8943-8949.
15.
Boyan BD, Schwartz Z., Bonewald LF, Swain LD (1989). Localization of 1,25-(OH)2D3 responsive alkaline phosphatase in osteoblast-like cells (ROS 17/2.8, MG 63, and MC 3T3) and growth cartilage cells in culture. J Biol Chem264:11879-11886.
16.
Boyan BD, Schwartz Z., Park-Snyder S., Dean DD, Yang F., Twardzik D., et al. (1994). Latent transforming growth factor-β is produced by chondrocytes and activated by extracellular matrix vesicles upon exposure to 1,25-(OH)2D3. J Biol Chem269:28374-28381.
17.
Boyan BD, Batzer R., Kieswetter K., Liu Y., Cochran DL, Szmuckler-Moncler S., et al. (1998). Titanium surface roughness alters responsiveness of MG63 osteoblast-like cells to 1α,25-(OH)2D3. J Biomed Mater Res39:77-85.
18.
Branemark P-I (1985). Tissue integrated prosthesis osteointegration in clinical dentistry. In: Tissue-integrated prostheses: osseointergration in clinical dentistry. Branemark P-I., Zarb GA, Albrektsson T., editors. Chicago, IL: Quintessence Publishing Co., pp. 11-76.
19.
Braun G., Kohavi D., Amir D., Luna MH, Caloss R., Sela J., et al. (1995). Markers of primary mineralization are correlated with bone-bonding ability of titanium or stainless steel in vivo. Clin Oral Implants Res6:1-13.
20.
Bronckers AL, Farach-Carson MC, van Waveren E., Butler WT (1994). Immunolocalization of osteopontin, osteocalcin, and dentin sialoprotein during dental root formation and early cementogenesis . J Bone Min Res9:833-841.
21.
Brunette DM (1986). Spreading and orientation of epithelial cells on grooved substrata. Exp Cell Res167:203-217.
22.
Brunette DM (1988). The effects of implant surface topography on the behavior of cells. Int J Oral Maxillofac Implants3:231-246.
23.
Brunette DM, Ratkay J., Chehroudi B. (1991). The behavior of osteoblasts on micromachined surfaces . In: Bone-biomaterials interface. Davies JE, editor. Toronto: University of Toronto Press, pp. 170-179.
24.
Canalis E., McCarthy TL, Centrella M. (1989). Effects of platelet-derived growth factor on bone formation in vitro. J Cell Physiol140:530-537.
25.
Caplan AI, Boyan BD (1994). Endochondral bone formation: the lineage cascade . In: Bone 8. Mechanisms of bone development and growth. Hall BK, editor. Boca Raton: CRC Press, pp. 1-46.
26.
Chehroudi B., Gould Trl, Brunette DM (1989). Effects of grooved titanium coated implant surface on epithelial cell behaviour in vitro and in vivo. J Biomed Mater Res23:1067-1085.
27.
Chehroudi B., Gould Trl, Brunette DM (1990). Titanium-coated micromachined grooves ot different dimensions affect epithelial and connective tissue cells differently in vivo . J Biomed Mater Res24:1203-1219.
28.
Chen D., Chen H., Feng JQ, Windle JJ, Koop BA, Harris HA, et al. (1995). Osteoblastic cell lines derived from a transgenic mouse containing the osteocalcin promoter driving the SV40 T-antigen . Mol Cell Differentiation3:193-212.
29.
Chicurel ME, Singer RH, Meyer CJ, Ingber DE (1998). Integrin binding and mechanical tension induce movement of mRNA and ribosomes to focal adhesions. Nature392:730-733.
30.
Cochran DL, Nummikoski PV, Higgenbottom FL, Hermann JS, Makins SR, Buser D. (1996). Evaluation of an endosseous titanium implant with a sandblasted and acid-etched surface in the canine mandible: radiographic results. Clin Oral Implants Res7:240-252.
31.
Dallas SL, Miyazono K., Skerry TM, Mundy GR, Bonewald LF (1995). Dual role for the latent transforming growth factor-β binding protein in storage of latent TGF-β in the extracellular matrix and as a structural matrix protein. J Cell Biol131:539-549.
32.
Damji A., Weston L., Brunette DM (1996). Directed confrontations between fibroblasts and epithelial cells on micromachined grooved substrata. Exp Cell Res228:114-124.
33.
Einhorn TA, Simon G., Devlin VJ, Sidhu SP, Vigorita VJ (1990). The osteogenic response to distant skeletal injury . J Bone Joint Surg (Am)72:1374-1378.
34.
Eisenbarth E., Meyle J., Nachtigall W., Breme J. (1996). Influence of the surface structure of titanium materials on the adhesion of fibroblasts. Biomaterials17:1399-1403.
35.
Fawthrop FW, Frazer A., Russell RG, Bunning RA (1997). Effects of transforming growth factor beta on the production of prostaglandin E and caseinase activity of unstimulated and interleukin-1-stimulated human articular chondrocytes in culture. Br J Rheumatol36:729-734.
36.
Gronowicz G., McCarthy MB (1996). Response of human osteoblasts to implant materials: integrin-mediated adhesion. J Orthop Res14:878-887.
37.
Hansson HA, Albrektsson T., Branemark P-I (1983). Structural aspects of the interface between tissue and titanium implants. J Prosthet Dent50:108-113.
38.
Hay DI, Moreno EC (1979). Differential adsorption and chemical affinities of proteins for apatitic surfaces. J Dent Res58:930-942.
39.
Hazan R., Brener R., Oron U. ( 1993). Bone growth to metal implants is regulated by their surface chemical properties. Biomaterials14:570-574.
40.
Hench LL, Paschall HA (1973). Direct chemical bond of bioactive glass-ceramic materials to bone and muscle. J Biomed Mater Res7:25-42.
41.
Hunter A., Archer CW, Walker PS, Blunn GW (1995). Attachment and proliferation of osteoblasts and fibroblasts on biomaterials for orthopaedic use. Biomaterials16:287-295.
42.
Jaaskelainen T., Pirskanen A., Ryhanen S., Palvimo JJ, DeLuca HF, Maenpaa PH (1994). Functional interference between AP-1 and the vitamin D receptor on osteocalcin gene expression in human osteosarcoma cells. Eur J Biochem224:11-20.
43.
Jarcho M., Kay JK, Gumaer RH, Doremus RH, Drobeck HP (1977). Tissue, cellular, and subcellular events at a bone-ceramic hydroxylapatite interface. J Bioengineering1 :79-92.
44.
Kasemo B. (1983). Biocompatibility of titanium implants: surface science aspects. J Prosthet Dent49:832-837.
45.
Kato Y., Windle JJ, Koop BA, Mundy GR, Bonewald LF (1997). Establishment of an osteocyte-like cell line, MLO-Y4. J Bone Miner Res12:2014-2023.
46.
Kieswetter K., Schwartz Z., Hummert TW, Cochran DL, Simpson J., Dean DD, et al. (1996). Surface roughness modulates the local production of growth factors and cytokines by osteoblast-like MG63 cells. J Biomed Mater Res32:55-63.
47.
Kilpadi DV, Lemons JE (1994). Surface energy characterization of unalloyed titanium implants. J Biomed Mater Res28:1419-1425.
48.
Kyeyune-Nyombi E., Lau KH, Baylink DJ, Strong DD (1991). 1,25-Dihydroxyvitamin D3 stimulates bone alkaline phosphatase gene transcription and mRNA stabilization in human bone cells . Arch Biochem Biophys291:316-325.
49.
Lincks J., Boyan BD, Blanchard CR, Lohmann CH, Liu Y., Cochran DL, et al. (1998). Response of MG63 osteoblast-like cells to titanium and titanium alloy is dependent on surface roughness and composition . Biomaterials19:2219-2232.
Martin JY, Schwartz Z., Hummert TW, Schraub DM, Simpson J.Lankford J., et al. (1995). Effect of titanium surface roughness on proliferation, differentiation, and protein synthesis of human osteoblast-like cells (MG63). J Biomed Mater Res29:389-401.
52.
Martin JY, Dean DD, Cochran DL, Simpson J., Boyan BD, Schwartz Z. (1996). Proliferation, differentiation, and protein synthesis of human osteoblast-like cells (MG63) cultured on previously used titanium surfaces. Clin Oral Implants Res7:27-37.
53.
Maxian SH, DiStefano T., Melican MC, Tiku ML, Zawadsky JP (1998). Bone cell behavior on Matrigel-coated Ca/P coatings of varying crystallinities. J Biomed Mater Res40:171-179.
54.
McCabe LR, Last TJ, Lynch M., Lian J., Stein J., Stein G. (1994). Expression of cell growth and bone phenotypic genes during the cell cycle of normal diploid osteoblasts and osteosarcoma cells. J Cell Biochem56:274-282.
55.
Miyazono K., Hellman U., Wernstedt C., Heldin CH (1988). Latent high molecular weight complex of transforming growth factor β1. Purification from human platelets and structural characterization . J Biol Chem263:6407-6415.
56.
Mundy GR (1991). The effects of TGF-β on bone. Ciba Found Symp157:137-151.
57.
Ong JL, Carnes DL, Cardenas HL, Cavin R. (1997). Surface roughness of titanium on bone morphogenetic protein-2-treated osteoblast cells in vitro. Implant Dent6:19-24.
58.
Oursler MJ (1994). Osteoclast synthesis and secretion and activation of latent transforming growth factor-beta. J Bone Miner Res9:443-452.
59.
Owen TA, Aronow M., Shalhoub V., Barone LM, Wilming L., Tassinari MS, et al. (1990). Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J Cell Physiol143:420-430.
60.
Pedrozo HA, Schwartz Z., Mokeyev T., Ornoy A., Xin-Sheng W., Bonewald LF, et al. (1999). Vitamin D3 metabolites regulate LTBP1 and latent TGF-β1 expression and latent TGF-β1 incorporation in the extracellular matrix of chondrocytes. J Cell Biochem72:151-165.
61.
Raisz LG, Fall PM ( 1990). Biphasic effects of prostaglandin E2 on bone formation in cultured fetal rat calvariae: interaction with cortisol. Endocrinology126:1654-1659.
62.
Rajpurohit R., Koch CJ, Tao Z., Teixeira CM, Shapiro IM (1996). Adaptation of chondrocytes to low oxygen tension: relationship between hypoxia and cellular metabolism. J Cell Physiol168:424-432.
63.
Richards RG (1996). The effect of surface roughness on fibroblast adhesion in vitro. Injury27:SC38-SC43.
64.
Schroeder A., Buser DA (1989). ITI-system. Basic and clinical procedures. Shigaku-Odontol77(Spec): 1267-1288.
65.
Schwartz Z., Boyan BD (1988). The effects of vitamin D metabolites on phospholipase A2 activity of growth zone and resting zone cartilage cells in vitro. Endocrinology122:2191-2198.
66.
Schwartz Z., Amir D., Boyan BD, Cochavy D., Muller-Mai C., Swain LD, et al. (1991). Effect of glass ceramic and titanium implants on primary calcification during rat tibial bone healing. Calcif Tissue Int49:359-364.
67.
Schwartz Z., Dennis R., Bonewald LF, Swain LD, Gomez R., Boyan BD (1992). Differential regulation of prostaglandin E2 synthesis and phospholipase A2 activity by 1,25-(OH)2D3 in three osteoblast-like cell lines (MC-3T3-E1, ROS 17/2.8, and MG-63). Bone13:51-58.
68.
Schwartz Z., Martin JY, Dean DD, Simpson J., Cochran DL, Boyan BD (1996). Effect of titanium surface roughness on chondrocyte proliferation, matrix production, and differentiation depends on the state of cell maturation. J Biomed Mater Res30:145-155.
69.
Scutt A., Bertram P. (1995). Bone marrow cells are targets for the anabolic actions of prostaglandin E2 on bone: induction of a transition from nonadherent to adherent osteoblast precursors. J Bone Min Res10:474-487.
70.
Sedlmayr P., Blaschitz A., Wilders-Truschnig M., Tiran A., Dohr G. ( 1995). Platelets contain interleukin-1 alpha and beta which are detectable on the cell surface after activation. Scand J Immunol42:209-214.
71.
Sela J., Shani J., Kohavi D., Soskolne WA, Itzhak K., Boyan BD, et al. (1995). Uptake and biodistribution of 99mtechnetium methylene-[32P]diphosphonate during endosteal healing around titanium, stainless steel and hydroxyapatite implants in rat tibial bone. Biomaterials16:1373-1380.
72.
Sell S., Gaissmaier C., Fritz J., Herr G., Esenwein S., Kusswetter W., et al. (1998). Different behavior of human osteoblast-like cells isolated from normal and heterotopic bone in vitro. Calcif Tissue Int62:51-59.
73.
Seyedin S., Thompson AY, Bentz H., Rosen DM, McPherson J., Conti A., et al. (1986). Cartilage inducing factor-A. Apparent identity to transforming growth factor-beta. J Biol Chem261:5693-5695.
74.
Sinha RK, Tuan RS ( 1996). Regulation of human osteoblast integrin expression by orthopaedic implant materials. Bone18:451-457.
75.
Sinha RK, Morris F., Shah SA, Tuan RS ( 1994). Surface composition of orthopaedic implant metals regulates cell attachment, spreading, and cytoskeletal organization of primary human osteoblasts in vitro. Clin Orthop Rel Res305:258-272.
76.
Suzuki A., Tokuda H., Kotoyori J., Ito Y., Oiso Y., Kozawa 0 (1994). Effect of vitamin D3 on prostaglandin E2 synthesis in osteoblast-like cells. Prostaglandins, Leukotrienes, and Essential Fatty Acids51:27-31.
77.
Takahashi GW, Moran D., Andrews DF, Singer JW (1994). Differential expression of collagenase by human fibroblasts and bone marrow stromal cells. Leukemia8:305-308.
78.
Thomas KA, Cook SD ( 1985). An evaluation of variables influencing implant fixation by direct bone apposition. J Biomed Mater Res19:875-901.
Ungersbock A., Pohler OE, Perren SM (1996). Evaluation of soft tissue reactions at the interface of titanium limited contact dynamic compression plate implants with different surface treatments. An experimental sheep study. Biomaterials17:797-806.
81.
von Recum AF, van Kooten TG (1995). The influence of microtopography on cellular response and the implications for silicone implants. J Biomater Sci Polym Ed7:181-198.
82.
Wehrbein H., Merz BR, Diedrich P., Glatzmaier J. (1996). The use of palatal implants for orthodontic anchorage. Design and clinical application of the orthosystem. Clin Oral Implants Res7:410-416.
